Understanding GLP-1, Dual & Triple Agonists

Introduction

You’ve probably heard names like Ozempic, Wegovy, Mounjaro and Retatrutide. They are often grouped together as “GLP-1 medications”, but that’s not the full story. While some medications only target the GLP-1 receptor, newer treatments work on two or even three different hormone receptors, which is why you’ll hear terms like dual agonist and triple agonist.

In this guide, we’ll explain what these medications are, how they work, what makes them different, and why they’ve become one of the biggest advances in obesity and weight management—all in simple, easy-to-understand language.

What Are Incretin Medications?

Most people refer to medications like Ozempic, Mounjaro and Retatrutide as “GLP-1 medications.” While this isn’t entirely incorrect, it’s not the full picture.

These medications belong to a broader group called incretin-based therapies. They work by mimicking naturally occurring hormones that help regulate appetite, blood sugar, digestion and energy balance.

Some medications activate one receptor, some activate two, and newer medications activate three.

💡 Key Point: Incretin medications mimic natural hormones that help regulate appetite, blood sugar and digestion. The more hormone receptors a medication targets, the broader its potential effects.

The Three Hormones

The three hormones below each play a different role in regulating appetite, blood sugar and energy balance. Different medications activate different combinations of these hormones.

Hormone	Main Role
GLP-1	Reduces appetite, slows stomach emptying and improves blood sugar control.
GIP	Supports insulin release and may enhance the effects of GLP-1 on appetite and fat metabolism.
Glucagon	Helps increase energy expenditure and influences how the body uses stored fat and glucose.

Think of these hormones as three different “switches”. Different medications turn on different combinations of these switches to produce their effects.

💡 Key Point: Each hormone has a different role. GLP-1 mainly reduces appetite, GIP works alongside GLP-1 to improve metabolic control, and glucagon may increase the amount of energy your body uses.

Single, Dual & Triple Agonists

Type	Targets	Example
Single Agonist	GLP-1	Semaglutide (Ozempic, Wegovy), Liraglutide (Saxenda)
Dual Agonist	GLP-1 + GIP	Tirzepatide (Mounjaro)
Triple Agonist	GLP-1 + GIP + Glucagon	Retatrutide (Reta)**

**At the time of writing, Retatrutide is still being investigated in clinical trials and has not yet received widespread regulatory approval.

💡 Key Point: The main difference between these medications is the number of hormone receptors they activate, not simply how “strong” they are. More receptors can produce different effects, but that doesn’t necessarily mean a medication is better for everyone.

Why Do They Work So Well?

They mainly help people lose weight by:

Eating less without feeling deprived.
Feeling full for longer after meals.
Reducing cravings and “food noise.”
Improving blood sugar regulation.
Helping many people stick to a calorie deficit more easily.

💡 Key Point: These medications don’t burn fat directly. They help many people eat fewer calories by reducing hunger, improving fullness and making it easier to maintain a calorie deficit.

Key Takeaways

Not every medication is simply a “GLP-1.”
Some medications target one hormone.
Others target two or three.
The more receptors a medication activates, the more complex its effects may be—but that doesn’t automatically make it “better” for every person.
Lifestyle factors such as nutrition, exercise and sleep remain important alongside any medication.

💡 Key point: Whether a medication targets one, two or three hormone receptors, lasting results are still best supported by healthy eating habits, regular physical activity, quality sleep and long-term lifestyle changes.

Ready to Go Beyond the Basics?

If you’d like a more detailed, evidence-based guide covering:

✔ How these medications actually work

✔ Expected weight loss

✔ Side effects

✔ Nutrition

✔ Training

✔ Long-term success

our Fat Loss & GLP-1 Guide takes these topics much further.

→ View the Fat Loss & GLP-1 Guide

Continue Learning

📚 Explore our in-depth articles on GLP-1, GIP, glucagon, Semaglutide, Tirzepatide and Retatrutide or dive deeper with our Fat Loss & GLP-1 Guide for practical advice and evidence-based explanations.